{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:59:11Z","timestamp":1790222351066,"version":"4.1.0"},"reference-count":68,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T00:00:00Z","timestamp":1595721600000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The increasingly frequent use of immunomodulatory agents in dermatology requires the observance of specific recommendations for immunization. These recommendations are developed and regularly updated by the German Standing Committee on Vaccination (STIKO), an independent advisory group at the Robert Koch Institute. Dermatological patients on immunosuppressive treatment should ideally receive all vaccinations included in the standard immunization schedule. Additionally, it is recommended that they also undergo vaccination against the seasonal flu, pneumococci, and herpes zoster (inactivated herpes zoster subunit vaccine for patients \u2265 50 years). Additional immunizations against<jats:italic>Haemophilus influenzae<\/jats:italic>type B, hepatitis B and meningococci may be indicated depending on individual comorbidities and exposure risk. Limitations of use, specific contraindications and intervals to be observed between vaccination and immunosuppression depend on the immunosuppressive agent used and its dosing. Only under certain conditions may live\u2010attenuated vaccines be administered in patients on immunosuppressive therapy. Given its strong suppressive effect on the humoral immune response, no vaccines \u2013\u00a0except for flu shots \u2013 should be given within six months after rituximab therapy.<\/jats:p><jats:p>This CME article presents current recommendations on immunization in immunocompromised individuals, with a special focus on dermatological patients. Its goal is to enable readers to provide competent counseling and to initiate necessary immunizations in this vulnerable patient group.<\/jats:p>","DOI":"10.1111\/ddg.14156","type":"journal-article","created":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T16:55:11Z","timestamp":1595782511000},"page":"699-723","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunizations in immunocompromised patients: a guide for dermatologists"],"prefix":"10.1111","volume":"18","author":[{"given":"Sophia","family":"Mohme","sequence":"first","affiliation":[{"name":"Department of Dermatology Venereology and Allergology University Hospital W\u00fcrzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schmalzing","sequence":"additional","affiliation":[{"name":"Department of Medicine II Rheumatology\/Clinical Immunology University Hospital W\u00fcrzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia S.L.","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Dermatology Venereology and Allergology Saarland University Homburg\/Saar Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vogt","sequence":"additional","affiliation":[{"name":"Department of Dermatology Venereology and Allergology Saarland University Homburg\/Saar Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Goebeler","sequence":"additional","affiliation":[{"name":"Department of Dermatology Venereology and Allergology University Hospital W\u00fcrzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Stoevesandt","sequence":"additional","affiliation":[{"name":"Department of Dermatology Venereology and Allergology University Hospital W\u00fcrzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,7,26]]},"reference":[{"key":"e_1_2_33_2_1","first-page":"313","article-title":"Empfehlungen der St\u00e4ndigen Impfkommission beim Robert Koch\u2010Institut \u2013 2019\/2020","volume":"34","year":"2019","journal-title":"Epid Bull"},{"key":"e_1_2_33_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.03.017"},{"key":"e_1_2_33_4_1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/ddg.13516","article-title":"S3 Guideline for the treatment of psoriasis vulgaris, update \u2013 Short version part 1 \u2013 Systemic treatment","volume":"16","author":"Nast A","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"key":"e_1_2_33_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-019-02905-1"},{"key":"e_1_2_33_6_1","first-page":"541","article-title":"Mitteilung der St\u00e4ndigen Impfkommission (STIKO) beim RKI: Wissenschaftliche Begr\u00fcndung zur Empfehlung einer Impfung mit dem Herpes zoster\u2010subunit\u2010Totimpfstoff","volume":"50","year":"2018","journal-title":"Epid Bull"},{"key":"e_1_2_33_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-017-2555-4"},{"key":"e_1_2_33_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-018-2761-8"},{"key":"e_1_2_33_9_1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00103-020-03123-w","article-title":"Impfen bei Immundefizienz: Anwendungshinweise zu den von der St\u00e4ndigen Impfkommission empfohlenen Impfungen. (III) Impfen bei h\u00e4matologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzelltransplantation), Organtransplantation und Asplenie","volume":"63","author":"Laws HJ","year":"2020","journal-title":"Bundesgesundheitsblatt"},{"key":"e_1_2_33_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw675"},{"key":"e_1_2_33_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.06.030"},{"key":"e_1_2_33_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.01.047"},{"key":"e_1_2_33_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000788"},{"key":"e_1_2_33_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.06.012"},{"key":"e_1_2_33_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215882"},{"key":"e_1_2_33_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.12.073"},{"key":"e_1_2_33_17_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6803a1"},{"key":"e_1_2_33_18_1","first-page":"CD008983","article-title":"Influenza vaccines in immunosuppressed adults with cancer","volume":"2","author":"Bitterman R","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_33_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.6768"},{"key":"e_1_2_33_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken436"},{"key":"e_1_2_33_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30070-3"},{"key":"e_1_2_33_22_1","unstructured":"S2k\u2010Leitlinie Diagnostik und Therapie des Pemphigus vulgaris \/ foliaceus und des bull\u00f6sen Pemphigoids. Available fromhttps:\/\/www.awmf.org\/leitlinien\/detail\/ll\/013\u2010071.html[Last accessed June 8 2020]."},{"key":"e_1_2_33_23_1","first-page":"365","article-title":"Mitteilung der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch\u2010Institut (RKI): Wissenschaftliche Begr\u00fcndung f\u00fcr die \u00c4nderung der Empfehlung zur Impfung gegen Hepatitis B","volume":"36","year":"2013","journal-title":"Epid Bull"},{"key":"e_1_2_33_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1265715"},{"key":"e_1_2_33_25_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6703a5"},{"key":"e_1_2_33_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw232"},{"key":"e_1_2_33_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.5486"},{"key":"e_1_2_33_28_1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/RHU.0000000000000866","article-title":"Lack of uptake of prophylactic human papilloma virus vaccine among women with systemic lupus erythematosus seen at a regional medical center","volume":"25","author":"Dhar JP","year":"2019","journal-title":"J Clin Rheumatol"},{"key":"e_1_2_33_29_1","first-page":"1","article-title":"Aktuelle Daten und Informationen zu Infektionskrankheiten und Public Health: Empfehlung und wissenschaftliche Begr\u00fcndung f\u00fcr die Angleichung der beruflich indizierten Masern\u2010Mumps\u2010R\u00f6teln (MMR\u2010) und Varizellen\u2010Impfung","volume":"2","year":"2020","journal-title":"Epid Bull"},{"key":"e_1_2_33_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001030050004"},{"key":"e_1_2_33_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-015-2253-z"},{"key":"e_1_2_33_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-019-00759-y"},{"key":"e_1_2_33_33_1","first-page":"352","article-title":"Mitteilung der St\u00e4ndigen Impfkommission (STIKO) beim RKI: Zur Kombinationsimpfung gegen Masern, Mumps, R\u00f6teln und Varizellen (MMRV)","volume":"38","year":"2011","journal-title":"Epid Bull"},{"key":"e_1_2_33_34_1","first-page":"252","article-title":"Reliability of varicella history in children and adolescents","volume":"135","author":"Heininger U","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"e_1_2_33_35_1","first-page":"385","article-title":"Mitteilung der St\u00e4ndigen Impfkommission am Robert Koch\u2010Institut (RKI): Wissenschaftliche Begr\u00fcndung f\u00fcr die Aktualisierung der Empfehlungen zur Indikationsimpfung gegen Pneumokokken f\u00fcr Risikogruppen","volume":"37","year":"2016","journal-title":"Epid Bull"},{"key":"e_1_2_33_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.733"},{"key":"e_1_2_33_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2007.06488.x"},{"key":"e_1_2_33_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.03.049"},{"key":"e_1_2_33_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24679"},{"key":"e_1_2_33_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199810)41:10<1828::AID-ART15>3.0.CO;2-T"},{"key":"e_1_2_33_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13001"},{"key":"e_1_2_33_42_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02426"},{"key":"e_1_2_33_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.08.010"},{"key":"e_1_2_33_44_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000409"},{"key":"e_1_2_33_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.07.048"},{"key":"e_1_2_33_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30325"},{"key":"e_1_2_33_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00386-12"},{"key":"e_1_2_33_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-017-0249-y"},{"key":"e_1_2_33_49_1","article-title":"Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitor","author":"Keam B","year":"2019","journal-title":"Clin Infect Dis"},{"key":"e_1_2_33_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0353-7"},{"key":"e_1_2_33_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz202"},{"key":"e_1_2_33_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.07.006"},{"key":"e_1_2_33_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200637"},{"key":"e_1_2_33_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel366"},{"key":"e_1_2_33_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211128"},{"key":"e_1_2_33_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201393"},{"key":"e_1_2_33_57_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.077461"},{"key":"e_1_2_33_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.25034"},{"key":"e_1_2_33_59_1","first-page":"272","article-title":"Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine JL","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_33_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izx001"},{"key":"e_1_2_33_61_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130945"},{"key":"e_1_2_33_62_1","first-page":"1356","article-title":"Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept","volume":"31","author":"Mease PJ","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_33_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.12.030"},{"key":"e_1_2_33_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2015.10.017"},{"key":"e_1_2_33_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.083"},{"key":"e_1_2_33_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.08.008"},{"key":"e_1_2_33_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000615"},{"key":"e_1_2_33_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21800"},{"key":"e_1_2_33_69_1","first-page":"1122","article-title":"Immune response to pneumococcus and tetanus toxoid in patients with moderate\u2010to\u2010severe psoriasis following long\u2010term ustekinumab use","volume":"12","author":"Brodmerkel C","year":"2013","journal-title":"J Drugs Dermatol"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fddg.14156","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.14156","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ddg.14156","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.14156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T21:35:20Z","timestamp":1696455320000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ddg.14156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1111\/ddg.14156"],"URL":"https:\/\/doi.org\/10.1111\/ddg.14156","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"2020-04-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}